title: Fetal impact of cholestasis of pregnancy: experience at Tenon Hospital and literature review.
abstract: Cholestasis of pregnancy is a liver disorder that occurs during the second half of pregnancy, causing pruritus and elevated serum bile acid levels. Its etiology remains unknown but probably involves vascular and humoral immune responses, mediated by bile acids. This disorder is associated with substantially increased fetal morbidity and mortality. The most satisfactory treatment consists in delivering the fetus as soon as pulmonary maturation has occurred.
authors.affiliation: Service de Gynécologie, obstétrique et médecine de la reproduction, Hôpital Tenon, Paris, France. rgaudet@club-internet.fr
authors.forename: R
authors.initials: R
authors.lastname: Gaudet
authors.forename: P
authors.initials: P
authors.lastname: Merviel
authors.forename: N
authors.initials: N
authors.lastname: Berkane
authors.forename: S
authors.initials: S
authors.lastname: Schouppe
authors.forename: J J
authors.initials: JJ
authors.lastname: Cocheton
authors.forename: S
authors.initials: S
authors.lastname: Uzan
mesh_terms: D000328:Adult; D001647:Bile Acids and Salts / Q000097:blood; D002779:Cholestasis / Q000150:complications* / Q000188:drug therapy; D005260:Female; D005313:Fetal Death / Q000209:etiology*; D005315:Fetal Diseases / Q000209:etiology*; D005316:Fetal Distress; D005317:Fetal Growth Retardation; D006340:Heart Rate, Fetal; D006801:Humans; D008470:Meconium; D011247:Pregnancy; D011248:Pregnancy Complications; D014580:Ursodeoxycholic Acid / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D001647:Bile Acids and Salts; D014580:Ursodeoxycholic Acid